NCT06163482Recruiting
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
Changes in Postprandial Hormone Levels in Cystic Fibrosis Related Diabetes.
Source: ClinicalTrials.gov · Last updated 25 Aug 2026
Brief summary (registry, in English)
In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 61 (estimated)
- First submitted
- 27 Nov 2023
- Start date
- 28 Mar 2023
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- University of Cincinnati
- Diseases
- Cystic fibrosis
- NCT number
- NCT06163482
What you commit to
- Study type: Observational
- Planned participants: 61
- From 28 Mar 2023 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Transplant recipient
- Any prior history of diabetic ketoacidosis.
Other illness
- Known liver disease that would be expected to significantly impact metabolic variable as interpreted by a study doctor
- The presence of any other disease or condition, as interpreted by any one of the study doctors, that would be expected to confound the responses to liquid mixed meal or make participation in the study dangerous to the individual
Other
- Acute lung function decline or exacerbation within the last 3 months
- Use of systemic glucocorticoids
- Pregnancy
- People who are cognitively impaired
- People who do not speak English
- For CFRD patients, a daily insulin requirement that exceeds 0.8 U/kg/day
Who the study is looking for
- Diagnosed with cystic fibrosis
- Aged 18 to 45 years
- Males and females of any race and ethnicity
- Receiving highly effective CFTR modular therapy
Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Cincinnati Coordinator of this site? Confirm its status | Cincinnati | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.